Becton Dickinson looks to divest life sciences unit at $30 billion valuation, source says
Bengaluru: U.S. medical device maker Becton Dickinson is considering a potential separation of its life sciences unit at a valuation of about $30 billion, a person familiar with the matter said on Monday. The company could announce the separation of the …